Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
122,40 EUR | +4,88% | +3,29% | -6,99% |
11/09 | REDCARE PHARMACY : Jefferies nog altijd een koopadvies | ZD |
10/09 | REDCARE PHARMACY : Een koopadvies van Hauck & Aufhauser | ZD |
Toevoegen aan een lijst 0 geselecteerde | Omzet ($) (Y-1) | Nettomarge (Y-1) | Bedrijfsmarge (Y-1) | ROE (Y-1) | ROA (Y-1) | Hefboom (schuld/EBITDA) (Y-1) | |
---|---|---|---|---|---|---|---|
1,98 mld. | -0.67% | -0.21% | -3.82% | -1.51% | 2.78x | ||
7,52 mld. | +4.00% | +1.67% | +4.55% | +3.41% | -16.07x | ||
139 mld. | -2.21% | +2.78% | +11.92% | +3.68% | 1.66x | ||
7,23 mld. | +5.12% | +7.40% | +10.50% | +11.40% | -1.06x | ||
3,8 mld. | +3.27% | +2.37% | +5.95% | +4.37% | -13.65x | ||
2,32 mld. | +6.10% | +8.70% | +43.60% | +13.80% | -0.48x | ||
5,5 mld. | +4.11% | +7.24% | +21.59% | - | -0.68x | ||
2,32 mld. | +10.24% | +11.03% | +37.93% | +17.31% | 0.17x | ||
3,17 mld. | +6.25% | +9.10% | +15.44% | +6.25% | -0.8x | ||
8,61 mld. | +2.17% | +3.55% | +11.40% | +8.77% | 0.77x | ||
1,53 mld. | +5.73% | +8.13% | +27.34% | +7.15% | 2.53x | ||
3,45 mld. | +4.76% | +6.65% | +18.01% | +5.07% | -0.47x | ||
2,02 mld. | +2.71% | +4.90% | +23.52% | +5.96% | 1.66x | ||
670 mln. | +1.16% | +2.31% | +4.27% | - | -0.49x | ||
2,44 mld. | +3.16% | +5.66% | +6.97% | +3.30% | -2.05x | ||
1,2 mld. | +2.82% | +3.97% | +12.40% | +6.97% | - | ||
Gemiddelde | 12,05 mld. | +3,67% | +5,33% | +15,72% | +6,85% | -1,74x | |
Gewogen gemiddelde per kap. | 21,49 mld. | +3,71% | +5,15% | +15,71% | +7,09% | -3,64x |
- Beurs
- Aandelen
- Koers RDC
- Sector Redcare Pharmacy NV
- Financiële vergelijkingen